A significant association was also observed between E-cad expression and tumor differentiation, as abnormal E-cad expression was more frequent in poorly/undifferentiated carcinomas (96.0%) than in well-differentiated carcinomas (62.5%; p = 0.0115). Here, CDH1 is linked to carcinoma.